B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site

URLhttps://curated.tncontentexchange.com/partners/pr_
Sourcehttps://curated.tncontentexchange.com
Date Published01/28/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name B. Braun Medical Inc.
Parent company B. Braun Medical Inc.
Type of work Manufacturing
Reshoring category:Reshoring
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):1000
City reshored to:Daytona Beach
State(s) reshored to:FL
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredinfusion therapy, pain management, IV fluid
Find Reshoring Articles